Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VaPE-Tox: E-cigarette Pulmonary Toxicity
NCT02783768Phase 1Completed
- Sponsor
- Columbia University
- Start
- Mar 2017
- Primary completion
- Jul 2018
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial (2 arms), sponsored by Columbia University. Primary endpoints: Pulmonary Microvascular Blood Flow and Ventilation Defect Percentage. Started Mar 2017; status: completed.
Beyond the preview
Go deeper on NCT02783768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02783768.